Encube Ethicals Pvt. , backed by private equity firm Quadria Capital, is considering an initial public offering in Mumbai that could raise about $400 million, according to people familiar with the matter. The contract drug manufacturer has appointed JM Financial Ltd. and JPMorgan Chase & Co. as advisers and plans to hire more banks for the proposed share sale, the people said, asking not to be ide...
Encube Ethicals Pvt. , backed by private equity firm Quadria Capital, is considering an initial public offering in Mumbai that could raise about $400 million, according to people familiar with the matter. The contract drug manufacturer has appointed JM Financial Ltd. and JPMorgan Chase & Co. as advisers and plans to hire more banks for the proposed share sale, the people said, asking not to be identified because the information is private. Deliberations are ongoing and details including the size and valuation of the offering could change, the people said. Representatives for Encube and the banks didn’t immediately respond to requests for comment. Firms including Quadria and Gulf Islamic Investments acquired a minority stake in Encube in 2021, a transaction that valued the company at about $800 million, according to data provider Tracxn . Read More: Quadria Is Said to Weigh Stake Sale in $2 Billion Firm Encube Encube, which owns the topical anti-microbial brand Soframycin, recently paused plans to sell a majority stake due to a valuation mismatch, the Economic Times reported last week, citing people familiar with the matter. India’s market for IPOs has had a subdued start to 2026, following two consecutive years of record fundraising. Stocks have come under pressure from geopolitical tensions, slowing earnings growth and uneven foreign inflows. Still, many Indian companies are increasingly turning to capital markets to raise funds, signaling confidence that businesses with strong fundamentals and the right valuations will continue to attract demand. Founded in 1998, Encube manufactures creams, gels and ointments focused on dermatology and reproductive health in India and the US. It also provides contract development and manufacturing services from three plants in India.
Photo: Wang Guangyou Wang Guangyou, a former official of China’s top securities watchdog, is under investigation for suspected “serious disciplinary and legal violations”, the top graft-buster announced Saturday. The probe into the former head of the China Securities Regulatory Commission’s (CSRC) bureau in Hubei province may be connected to the listing of Tianfeng Securities Co. Ltd. , people fam...
Photo: Wang Guangyou Wang Guangyou, a former official of China’s top securities watchdog, is under investigation for suspected “serious disciplinary and legal violations”, the top graft-buster announced Saturday. The probe into the former head of the China Securities Regulatory Commission’s (CSRC) bureau in Hubei province may be connected to the listing of Tianfeng Securities Co. Ltd. , people familiar with this matter told Caixin.
Target (TGT +1.47%) has been one of the biggest flops in the retail sector since the pandemic ended. Over the last five years, the stock is down 30%, and is off more than 50% from its all-time peak around the same time. The company has struggled with theft, inflation, stiff competition from Walmart, Costco, and Amazon, a shifting political stance that has alienated its customers, and a deteriorati...
Target (TGT +1.47%) has been one of the biggest flops in the retail sector since the pandemic ended. Over the last five years, the stock is down 30%, and is off more than 50% from its all-time peak around the same time. The company has struggled with theft, inflation, stiff competition from Walmart, Costco, and Amazon, a shifting political stance that has alienated its customers, and a deteriorating in-store experience that have contributed to a decline in comparable store sales. Now, a new CEO has breathed new life into Target stock and investors see an opportunity for a turnaround. In a year when the S&P 500 is down, Target is up 18% year-to-date through March 23, largely because new CEO Michael Fiddelke has instilled a sense of confidence in the company's turnaround potential, even after middling fourth-quarter results earlier this month. Fiddelke hasn't wasted any time in rolling out new ideas to recover lost business, and a key test for the company is coming this week: Target's Circle Deal Days. What is Target Circle Deal Days? Target's Circle Deal Days is a three shopping promotion from March 25-27, seemingly designed to compete with Amazon's Big Spring sale, to promote Target Circle, its free loyalty program, and a Target Circle 360 membership program that offers similar benefits to Amazon Prime. Target Circle Deal Days offers 40% off or more on a wide range of items, and members who join Target Circle will get 15% off on one shopping trip. The focus on loyalty is part of a larger strategy under Fiddelke, which includes experiential benefits and rewards in specific categories like beauty or Starbucks. Circle Deal Days also gives the retail stock a chance to draw customers to its store, at a time when it wants to show customers that it's spruced up its stores with a refreshed product lineup, renewed commitment to customer service, and revamped store layouts. Fiddelke's top objective should be returning the business to comparable sales growth, and Circle Deal D...
Key Points Target has struggled since the pandemic. Investors are hopeful that new CEO Michael Fiddelke can inject some energy into the business. The Deal Days promotion is shaping up to be an early test for the company's turnaround strategy. 10 stocks we like better than Target › Target (NYSE: TGT) has been one of the biggest flops in the retail sector since the pandemic ended. Over the last five...
Key Points Target has struggled since the pandemic. Investors are hopeful that new CEO Michael Fiddelke can inject some energy into the business. The Deal Days promotion is shaping up to be an early test for the company's turnaround strategy. 10 stocks we like better than Target › Target (NYSE: TGT) has been one of the biggest flops in the retail sector since the pandemic ended. Over the last five years, the stock is down 30%, and is off more than 50% from its all-time peak around the same time. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » The company has struggled with theft, inflation, stiff competition from Walmart, Costco, and Amazon, a shifting political stance that has alienated its customers, and a deteriorating in-store experience that have contributed to a decline in comparable store sales. Now, a new CEO has breathed new life into Target stock and investors see an opportunity for a turnaround. In a year when the S&P 500 is down, Target is up 18% year-to-date through March 23, largely because new CEO Michael Fiddelke has instilled a sense of confidence in the company's turnaround potential, even after middling fourth-quarter results earlier this month. Fiddelke hasn't wasted any time in rolling out new ideas to recover lost business, and a key test for the company is coming this week: Target's Circle Deal Days. What is Target Circle Deal Days? Target's Circle Deal Days is a three shopping promotion from March 25-27, seemingly designed to compete with Amazon's Big Spring sale, to promote Target Circle, its free loyalty program, and a Target Circle 360 membership program that offers similar benefits to Amazon Prime. Target Circle Deal Days offers 40% off or more on a wide range of items, and members who join Target Circle will get 15% off on one shopping trip. The focus on loyalty is par...
On Monday, jurors in the social media addiction trial told the court that they are struggling to agree on a verdict involving one of the defendants. Jury Signals Deadlock After Weeklong Deliberations The jury has been deliberating for more than a week in a case centered on allegations that platforms such as YouTube and Instagram contributed to a young woman's addiction beginning at an early age. J...
On Monday, jurors in the social media addiction trial told the court that they are struggling to agree on a verdict involving one of the defendants. Jury Signals Deadlock After Weeklong Deliberations The jury has been deliberating for more than a week in a case centered on allegations that platforms such as YouTube and Instagram contributed to a young woman's addiction beginning at an early age. Judge Warns Of Possible Mistrial Los Angeles County Superior Court Judge Carolyn B Kuhl urged jurors to continue discussions and reach a decision if possible. However, she acknowledged that failure to come to a unanimous verdict could force the case to be retried with a new jury. Google and Meta did not immediately respond to Benzinga's request for comments. NYC Lawsuit Targets Meta, Alphabet And Others Previously, the Federal Trade Commission also launched a probe into the possible harms AI chatbots may pose to children and teens, including those deployed by Meta, Google and Snapchat. Price Action: Meta shares are up 0.17% in after-hours trading, reaching $605.40. During the same period, Alphabet Class A shares were down 0.17% and Class C shares gained 0.023%, reaching $301.70 and $299.09, respectively. Benzinga Edge Stock Rankings indicate that GOOG stock is underperforming in the short and mid-term, but shows strong long-term upside backed by a Quality score in the 95th percentile. Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. Photo Courtesy: Koshiro K On Shutterstock.com
Despite state bans and restrictions, the number of abortions in the U.S. holds steady toggle caption Saul Loeb/AFP via Getty Images Since the reversal of Roe v. Wade in 2022, anti-abortion rights advocates have continuously pursued laws and court cases to make access to abortion more difficult. A report published Tuesday finds those efforts haven't worked in one basic way: the number of abortions ...
Despite state bans and restrictions, the number of abortions in the U.S. holds steady toggle caption Saul Loeb/AFP via Getty Images Since the reversal of Roe v. Wade in 2022, anti-abortion rights advocates have continuously pursued laws and court cases to make access to abortion more difficult. A report published Tuesday finds those efforts haven't worked in one basic way: the number of abortions in the country hasn't budged. "There were an estimated 1,126,000 abortions provided by clinicians in the U.S. in 2025 — that's pretty much unchanged from 2024," says Isaac Maddow-Zimet, data scientist at the Guttmacher Institute, a nonprofit research organization that supports abortion access. Sponsor Message A key way that abortions are now happening despite all of the state restrictions is through telemedicine. In 2023, the Food and Drug administration under President Biden allowed mifepristone — one of the medications used for abortion — to be prescribed without an in-person appointment. At the same time, states that support abortion access have passed shield laws, which protect health care providers from legal risks when they prescribe to patients in states with bans. What that meant last year is that more people in states with restrictions had abortions through telemedicine, and fewer people traveled across state lines for abortion, according to the Guttmacher report. "It makes sense that we'd see a decline in travel because people accessing abortion care through telehealth in general then no longer need to travel for care," Maddow-Zimet says. Medication by mail When Viv found out she was pregnant last January, she was three days past Georgia's ban on abortion after six weeks of pregnancy. Viv is 27 years old and lives in Atlanta. NPR agreed not to use her last name because she fears repercussions for talking about her experience. She went online and looked through posts on Reddit, trying to figure out what to do. "I found out that I could get an abortion pill shipped ...